Home ART delivery
Participants randomized to the home ART delivery group will receive ART delivery at home or at a location of their choice, such as a community center. At ART delivery visits, a clinical screening questionnaire will be completed, and blood collected for viral load and creatinine tested as indicated by the clinical monitoring schedule following local guidelines. These procedures will be conducted by a study team member in person, with oversight from a nurse, or via telehealth with a nurse. If no-contact delivery is necessary due to COVID-19 restrictions, the participant will self-collect DBS for viral load testing and provide that when the medication is delivered. Participants will have a home delivery appointment scheduled 3 months after ART initiation.